83 related articles for article (PubMed ID: 20329760)
1. Differential protein expression in human articular chondrocytes expanded in serum-free media of different medium osmolalities by DIGE.
Koo J; Kim KI; Min BH; Lee GM
J Proteome Res; 2010 May; 9(5):2480-7. PubMed ID: 20329760
[TBL] [Abstract][Full Text] [Related]
2. Controlling medium osmolality improves the expansion of human articular chondrocytes in serum-free media.
Koo J; Kim KI; Min BH; Lee GM
Tissue Eng Part C Methods; 2010 Oct; 16(5):957-63. PubMed ID: 20001269
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia conditions differentially modulate human normal and osteoarthritic chondrocyte proteomes.
Ruiz-Romero C; Calamia V; Rocha B; Mateos J; Fernández-Puente P; Blanco FJ
J Proteome Res; 2010 Jun; 9(6):3035-45. PubMed ID: 20387907
[TBL] [Abstract][Full Text] [Related]
4. Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases.
Ruiz-Romero C; López-Armada MJ; Blanco FJ
Proteomics; 2005 Aug; 5(12):3048-59. PubMed ID: 16035116
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis.
Ruiz-Romero C; Carreira V; Rego I; Remeseiro S; López-Armada MJ; Blanco FJ
Proteomics; 2008 Feb; 8(3):495-507. PubMed ID: 18186017
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture.
Mandl EW; Jahr H; Koevoet JL; van Leeuwen JP; Weinans H; Verhaar JA; van Osch GJ
Matrix Biol; 2004 Jul; 23(4):231-41. PubMed ID: 15296937
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture.
Diaz-Romero J; Gaillard JP; Grogan SP; Nesic D; Trub T; Mainil-Varlet P
J Cell Physiol; 2005 Mar; 202(3):731-42. PubMed ID: 15389573
[TBL] [Abstract][Full Text] [Related]
8. Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo.
Pelttari K; Lorenz H; Boeuf S; Templin MF; Bischel O; Goetzke K; Hsu HY; Steck E; Richter W
Arthritis Rheum; 2008 Feb; 58(2):467-74. PubMed ID: 18240244
[TBL] [Abstract][Full Text] [Related]
9. Proteomic changes in articular cartilage of human endemic osteoarthritis in China.
Ma WJ; Guo X; Liu JT; Liu RY; Hu JW; Sun AG; Yu YX; Lammi MJ
Proteomics; 2011 Jul; 11(14):2881-90. PubMed ID: 21681992
[TBL] [Abstract][Full Text] [Related]
10. Differences in the secretome of cartilage explants and cultured chondrocytes unveiled by SILAC technology.
Polacek M; Bruun JA; Johansen O; Martinez I
J Orthop Res; 2010 Aug; 28(8):1040-9. PubMed ID: 20108312
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin-1beta.
Cillero-Pastor B; Ruiz-Romero C; Caramés B; López-Armada MJ; Blanco FJ
Arthritis Rheum; 2010 Mar; 62(3):802-14. PubMed ID: 20131227
[TBL] [Abstract][Full Text] [Related]
12. A serum free approach towards the conservation of chondrogenic phenotype during in vitro cell expansion.
Ho ST; Yang Z; Hui HP; Oh KW; Choo BH; Lee EH
Growth Factors; 2009 Oct; 27(5):321-33. PubMed ID: 19626506
[TBL] [Abstract][Full Text] [Related]
13. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
14. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
15. TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes.
Narcisi R; Signorile L; Verhaar JA; Giannoni P; van Osch GJ
Osteoarthritis Cartilage; 2012 Oct; 20(10):1152-60. PubMed ID: 22772045
[TBL] [Abstract][Full Text] [Related]
16. Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes.
Giovannini S; Diaz-Romero J; Aigner T; Mainil-Varlet P; Nesic D
J Cell Physiol; 2010 Feb; 222(2):411-20. PubMed ID: 19890919
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer.
Richmon JD; Sage AB; Shelton E; Schumacher BL; Sah RL; Watson D
Laryngoscope; 2005 Sep; 115(9):1553-60. PubMed ID: 16148694
[TBL] [Abstract][Full Text] [Related]
18. Chondrocytes isolated from tibial dyschondroplasia lesions and articular cartilage revert to a growth plate-like phenotype when cultured in vitro.
Wu LN; Ishikawa Y; Genge BR; Wuthier RE
J Cell Physiol; 2005 Jan; 202(1):167-77. PubMed ID: 15389532
[TBL] [Abstract][Full Text] [Related]
19. Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes.
Calamia V; Rocha B; Mateos J; Fernández-Puente P; Ruiz-Romero C; Blanco FJ
J Proteome Res; 2011 Aug; 10(8):3701-11. PubMed ID: 21692455
[TBL] [Abstract][Full Text] [Related]
20. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
Loeser RF; Pacione CA; Chubinskaya S
Arthritis Rheum; 2003 Aug; 48(8):2188-96. PubMed ID: 12905472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
